Rxsight Inc reports results for the quarter ended December 31 - Earnings Summary

• Rxsight Inc RXST.OQ reported a quarterly adjusted loss of 22 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -15 cents. The mean expectation of twelve analysts for the quarter was for a loss of 33 cents per share. Wall Street expected results to range from -44 cents to -25 cents per share.

• Revenue fell 18.9% to $32.61 million from a year ago; analysts expected $30.12 million.

• Rxsight Inc's reported EPS for the quarter was a loss of 22 cents​.

• The company reported a quarterly loss of $9.15 million.

• Rxsight Inc shares had fallen by 14.2% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.5% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 8 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

• Wall Street's median 12-month price target for Rxsight Inc is $10.00, about 11.9% above its last closing price of $8.81

This summary was machine generated from LSEG data February 26 at 01:45 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)